Healthcare & Biotech, Metals & Mining, Con...
- by Staff Editor
- Aug 17 2022
5 Day Gainers Report
Powered by HealthTechMovers.com We have identified 7 Five Day Gainers of all US Exchanges; they are receiving Bullish Sentiment from investors and financial bloggers.In addition, they are generating positive...
Pot Stock, Analysts
- by Staff Editor
- Jun 29 2022
Barclays Analyst Reiterates Sell Rating on Altria Group, MO
Gaurav Jain analyst at Barclays reiterates coverage on Altria Group (MO) in the Consumer Goods sector with a Sell rating. TipRanks.com has Jain rated as a 4.5 star analyst with a 65% return on investment and a 11.2% success rate....
Pot Stock, Analysts
- by Staff Editor
- Jun 29 2022
MKM Partners Analyst Reiterates Buy Rating on Canopy Growth, CGC
William Kirk analyst at MKM Partners reiterates coverage on Canopy Growth (CGC) in the Basic Materials sector with a Buy rating. TipRanks.com has Kirk rated as a 0.3 star analyst with a 40% return on investment and a -7% success...
Pot Stock, Insiders
- by Staff Editor
- Jun 08 2022
ACB Showing Recent Insider Activity
Recent activity shows that Aurora Cannabis, ACB the Insider Confidence level is trending Up due to Corporate Insiders of ACB Bought $144.8K worth of shares in the last 3 months. Before you dig into this report it...
Pot Stock, Analysts
- by Staff Editor
- Jun 02 2022
Piper Sandler Analyst Reiterates Sell Rating on Canopy Growth, CGC
Michael Lavery analyst at Piper Sandler reiterates coverage on Canopy Growth (CGC) in the Basic Materials sector with a Sell rating. TipRanks.com has Lavery rated as a 2.8 star analyst with a 50% return on investment and a 1.4% success...
Pot Stock, Analysts
- by Staff Editor
- May 25 2022
Canaccord Genuity Analyst Reiterates Sell Rating on Canopy Growth, CGC
Matt Bottomley analyst at Canaccord Genuity reiterates coverage on Canopy Growth (CGC) in the Basic Materials sector with a Sell rating. TipRanks.com has Bottomley rated as a 4.8 star analyst with a 49% return on investment and a 18% success...
Pot Stock, Insiders
- by Staff Editor
- May 25 2022
SMG Showing Recent Insider Activity
Recent activity shows that Scotts Miracle-Gro Company, SMG the Insider Confidence level is trending Down due to Corporate Insiders of SMG Sold $7.8M worth of shares in the last 3 months. Before you dig into this report...
Pot Stock, Insiders
- by Staff Editor
- May 25 2022
IIPR Showing Recent Insider Activity
Recent activity shows that Innovative Industrial Properties, IIPR the Insider Confidence level is trending Down due to Corporate Insiders of IIPR Sold $185.8K worth of shares in the last 3 months. Before you dig into this report...
Pot Stock, Analysts
- by Staff Editor
- May 24 2022
Bernstein Analyst Reiterates Hold Rating on Molson Coors, TAP
Trevor Stirling analyst at Bernstein reiterates coverage on Molson Coors (TAP) in the Consumer Goods sector with a Hold rating. TipRanks.com has Stirling rated as a 3.9 star analyst with a 65% return on investment and a 8.2% success rate....
Pot Stock, Insiders
- by Staff Editor
- May 20 2022
CRBP Showing Recent Insider Activity
Recent activity shows that Corbus Pharmaceuticals, CRBP the Insider Confidence level is trending Up due to Corporate Insiders of CRBP Bought $18.7K worth of shares in the last 3 months. Before you dig into this report it...
Pot Stock, Insiders
- by Staff Editor
- May 20 2022
SMG Showing Recent Insider Activity
Recent activity shows that Scotts Miracle-Gro Company, SMG the Insider Confidence level is trending Down due to Corporate Insiders of SMG Sold $7.8M worth of shares in the last 3 months. Before you dig into this report...
Health, Pot Stock, Watchlist
- by Staff Editor
- May 17 2022
May 17th: 3 Healthcare & Biotech Stocks up over 25% past 10 days
3 Healthcare & Biotech Stocks up over 25% past 10 daysPowered by HealthTechMovers.com Today, our screeners...
Pot Stock, Analysts, healthcare stocks
- by Staff Editor
- May 13 2022
BMO Capital Analyst Reiterates Buy Rating on AbbVie, ABBV
Gary Nachman analyst at BMO Capital reiterates coverage on AbbVie (ABBV) in the Healthcare sector with a Buy rating. TipRanks.com has Nachman rated as a 0.1 star analyst with a 36% return on investment and a -10.3% success rate. Nachman has...
Pot Stock, Analysts
- by Staff Editor
- May 13 2022
Cantor Fitzgerald Analyst Reiterates Hold Rating on Aurora Cannabis, ACB
Pablo Zuanic analyst at Cantor Fitzgerald reiterates coverage on Aurora Cannabis (ACB) in the Basic Materials sector with a Hold rating. TipRanks.com has Zuanic rated as a 4.4 star analyst with a 42% return on investment and a 9.3% success...
Pot Stock, Analysts, healthcare stocks
- by Staff Editor
- May 13 2022
Canaccord Genuity Analyst Reiterates Buy Rating on Clever Leaves Holdings, CLVR
Robert Burleson analyst at Canaccord Genuity reiterates coverage on Clever Leaves Holdings (CLVR) in the Healthcare sector with a Buy rating. TipRanks.com has Burleson rated as a 4.7 star analyst with a 53% return on investment and a 12.2% success...
Pot Stock, Analysts, healthcare stocks
- by Staff Editor
- May 13 2022
H.C. Wainwright Analyst Reiterates Buy Rating on Corbus Pharmaceuticals, CRBP
Andrew Fein analyst at H.C. Wainwright reiterates coverage on Corbus Pharmaceuticals (CRBP) in the Healthcare sector with a Buy rating. TipRanks.com has Fein rated as a 0 star analyst with a 20% return on investment and a -24.8% success rate....
Pot Stock, Analysts
- by Staff Editor
- May 13 2022
Bank of America Securities Analyst Reiterates Sell Rating on Cronos Group, CRON
Lisa Lewandowski analyst at Bank of America Securities reiterates coverage on Cronos Group (CRON) in the Basic Materials sector with a Sell rating. TipRanks.com has Lewandowski rated as a 3.9 star analyst with a 84% return on investment and a...
Pot Stock, Analysts, healthcare stocks
- by Staff Editor
- May 13 2022
H.C. Wainwright Analyst Reiterates Buy Rating on Cara Therapeutics, CARA
Oren Livnat analyst at H.C. Wainwright reiterates coverage on Cara Therapeutics (CARA) in the Healthcare sector with a Buy rating. TipRanks.com has Livnat rated as a 0.3 star analyst with a 38% return on investment and a -4.7% success rate....